GlassScriptPhysician profile
Ramsha A Tanwir
NPI 1255866737
$502.10
in general payments reported to CMS, 2019-2025
11 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.47 · 2021: $21.98 · 2022: $121 · 2023: $163 · 2024: $41.93 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $93.06 | 2024-2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $75.71 | 2022-2023 | Seglentis |
| Vaporox, INC. | $69.71 | 2023 | Vht-200 Wound Treatment System |
| Stryker Corporation | $60.40 | 2022 | |
| Horizon Therapeutics Plc | $45.57 | 2022 | |
| Medtronic, INC. | $43.52 | 2025 | Inceptiv |
| Organogenesis INC. | $32.58 | 2023 | Puraply |
| Kerecis Limited | $28.54 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $21.98 | 2021 | |
| Reprise Biomedical, INC. | $15.56 | 2024 | Miro3d |
| Wright Medical Technology, INC. | $15.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramsha Tanwir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.